Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June
Valneva will also discuss its Phase 3 Lyme disease vaccine candidate (VLA15) and its currently commercialized vaccine products during the conferences.
- Valneva will also discuss its Phase 3 Lyme disease vaccine candidate (VLA15) and its currently commercialized vaccine products during the conferences.
- Jefferies Healthcare Conference: Peter Buhler, Chief Financial Officer of Valneva will present on Wednesday, June 7, 2023, at 1.30pm ET.
- A replay of the webcast will be available following the live events in the “Investor” section of the Valneva website at www.valneva.com .
- Goldman Sachs Annual Global Healthcare Conference: The Company will be available for 1on1 investor meetings.